Original news and analysis on international IP policy
Por Tove Iren S. Gerhardsen Un funcionario tailandés afirma que los teléfonos del Gobierno han comenzado a sonar con mayor frecuencia desde que Tailandia concedió licencias obligatorias para importar y, finalmente, fabricar medicamentos patentados, lo cual ha obligado a los…
By Monika Ermert for Intellectual Property Watch The European Parliament this week passed a resolution on cross-border collective rights management asking for a framework directive at the EU level that would encourage more competition. But parliamentary members of the bigger…
By Stephen Flug for Intellectual Property Watch The World Intellectual Property Organization (WIPO) said there was a 25 percent increase in “cybersquatting” complaints – the registering and use of domain names to profit from another party’s trademark – last year…
By Tove Iren S. Gerhardsen A Thai official says the government’s phones have started ringing a lot more frequently since Thailand issued compulsory licenses to import and eventually produce patented medicines, moving patent owners to drop their prices. But sceptics…
By Tove Iren S. Gerhardsen The Indonesian government’s reluctance to share avian influenza virus samples to help develop a global vaccine for humans has revealed a weakness in the international flu research system related to developing countries’ concern with the…
By Tove Iren S. Gerhardsen The United States will pursue stronger intellectual property rights and enforcement in multilateral forums such as the World Trade Organization (WTO) as well as in free trade agreements and regional agreements, and is considering dispute…
By Monika Ermert for Intellectual Property Watch
For the third time since December, the European Parliament committee vote on an EU directive on criminal sanctions against infringers of intellectual property rights has been postponed. This is a signal that there are great difficulties with the text, say observers from non governmental organisations, who argue that the European Commission should kill it or rewrite it from scratch.
But a compromise is near, according to the vice chair of the Committee on Legal Affairs and the Internal Market (JURI), Rainer Wieland (EPP).
By Tove Iren S. Gerhardsen A new anti-malarial, non-patented drug available cheaply to the public sector is being hailed as proof that it is possible for the private and public sectors to overcome differences over patents and reach concrete results…
By William New The United States Patent and Trademark Office (USPTO) on 5 March announced a new report it said shows that distributors of the most popular filesharing programmes “repeatedly deployed features that they knew or should have known could…
By William New An informative event this week pitted key proponents of opposite views on how to best protect the intellectual property rights of pharmaceutical companies while also addressing the needs of poor patients around the world unable to afford…